HEPATIC TISSUE DISTRIBUTION OF DOXORUBICIN-LOADED NANOPARTICLES AFTER IV ADMINISTRATION IN RETICULOSARCOMA M-5076 METASTASIS-BEARING MICE

被引:96
作者
CHIANNILKULACHAI, N [1 ]
AMMOURY, N [1 ]
CAILLOU, B [1 ]
DEVISSAGUET, JP [1 ]
COUVREUR, P [1 ]
机构
[1] INST GUSTAVE ROUSSY,HISTOL LAB,F-94000 VILLEJUIF,FRANCE
关键词
D O I
10.1007/BF02897257
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In our previous studies, doxorubicin-loaded polyisohexylcyanoacrylate nanoparticles have been proven to increase dramatically the antitumoral activity of the cytotoxic agent in metastasis-bearing mice. The experimental model consisted of metastases induced by i.v. inoculation of reticulosarcoma M 5076 cell suspension to C57BL/6 mice. The improved efficacy of the drug was noted in terms of either metastasis count or survival. Therefore, tissue-distribution studies of this drug delivery system within the metastatic liver after i.v. administration were undertaken to gain more insight into the mechanism of action. Doxorubicin measurements in healthy hepatic or neoplastic tissue were carried out together with histological examinations using transmission electron microscopy. These results demonstrated the hepatic tissue to be an efficient reservoir of the drug when it was injected associated with nanoparticles. Accumulation of biodegradable nanoparticles with associated doxorubicin in Kupffer cells created a gradient of drug concentration for a massive and prolonged diffusion of the free drug towards the neoplastic tissue. © 1990 Springer-Verlag.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 23 条
[1]   A MURINE OVARIAN TUMOR WITH UNIQUE METASTASIZING CAPACITY [J].
ALESSANDRI, G ;
GIAVAZZI, R ;
FALAUTANO, P ;
SPREAFICO, F ;
GARATTINI, S ;
MANTOVANI, A .
EUROPEAN JOURNAL OF CANCER, 1981, 17 (06) :651-&
[2]   DOXORUBICIN-LOADED NANOPARTICLES - INCREASED EFFICIENCY IN MURINE HEPATIC METASTASES [J].
CHIANNILKULCHAI, N ;
DRIOUICH, Z ;
BENOIT, JP ;
PARODI, AL ;
COUVREUR, P .
SELECTIVE CANCER THERAPEUTICS, 1989, 5 (01) :1-11
[3]   TOXICITY OF POLYALKYLCYANOACRYLATE NANOPARTICLES .2. DOXORUBICIN-LOADED NANOPARTICLES [J].
COUVREUR, P ;
KANTE, B ;
GRISLAIN, L ;
ROLAND, M ;
SPEISER, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (07) :790-792
[4]  
COUVREUR P, 1985, DRUG TARGETING, P35
[5]  
Couvreur P., 1986, POLYM NANOPARTICLES, P27
[6]  
Couvreur P, 1982, US patent, Patent No. [4329332 A, 4329332]
[7]   SUPERIOR THERAPEUTIC ACTIVITY OF LIPOSOME-ASSOCIATED ADRIAMYCIN IN A MURINE METASTATIC TUMOR-MODEL [J].
GABIZON, A ;
GOREN, D ;
FUKS, Z ;
MESHORER, A ;
BARENHOLZ, Y .
BRITISH JOURNAL OF CANCER, 1985, 51 (05) :681-689
[8]  
GABIZON A, 1982, CANCER RES, V42, P4734
[9]   PHARMACOKINETICS AND DISTRIBUTION OF A BIODEGRADABLE DRUG-CARRIER [J].
GRISLAIN, L ;
COUVREUR, P ;
LENAERTS, V ;
ROLAND, M ;
DEPREZDECAMPENEERE, D ;
SPEISER, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (03) :335-345
[10]   PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED ANTI-TUMOR DRUGS - STUDIES WITH VINBLASTINE, ACTINOMYCIN-D, CYTOSINE-ARABINOSIDE, AND DAUNOMYCIN [J].
JULIANO, RL ;
STAMP, D .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :21-27